• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

威奇霉素,一种新型的螺环缩肽多酮类化合物,来源于 Actinocrispum wychmicini MI503-A4。

Wychimicins, a new class of spirotetronate polyketides from Actinocrispum wychmicini MI503-A4.

机构信息

Institute of Microbial Chemistry (BIKAKEN), 3-14-23 Kamiosaki, Shinagawa-ku, Tokyo, 141-0021, Japan.

出版信息

J Antibiot (Tokyo). 2022 Oct;75(10):535-541. doi: 10.1038/s41429-022-00560-4. Epub 2022 Sep 7.

DOI:10.1038/s41429-022-00560-4
PMID:36071214
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9449258/
Abstract

In the course of our screening program for new anti-methicillin-resistant Staphylococcus aureus antibiotics, four novel antibiotics, termed wychimicins A-D, were isolated from the culture broth of the rare actinomycete Actinocrispum wychmicini strain MI503-AF4. Wychimicins are spirotetronates possessing a macrocyclic 13-membered ring containing trans-decalin and β-D-xylo-hexopyranose moieties connected to C-17 by an O-glycosidic linkage according to MS, NMR and X-ray analyses. In X-ray crystal structure analysis, the Flack constant was 0.10 (11). The stereochemistry of the spirocarbon C-25 was R. Wychimicins had a minimum inhibitory concentration of 0.125-2 µg ml against methicillin-resistant Staphylococcus aureus.

摘要

在我们筛选新型抗耐甲氧西林金黄色葡萄球菌抗生素的过程中,从稀有放线菌 Actinocrispum wychmicini 菌株 MI503-AF4 的发酵液中分离出四种新型抗生素,称为 wychimicins A-D。Wychimicins 是一种具有大环 13 元环的螺缩环四烯,其中包含反式十氢化萘和 β-D-木戊吡喃糖部分,根据 MS、NMR 和 X 射线分析,通过 O-糖苷键连接到 C-17。在 X 射线晶体结构分析中,Flack 常数为 0.10(11)。螺缩碳 C-25 的立体化学为 R。Wychimicins 对耐甲氧西林金黄色葡萄球菌的最小抑制浓度为 0.125-2µg·ml-1。

相似文献

1
Wychimicins, a new class of spirotetronate polyketides from Actinocrispum wychmicini MI503-A4.威奇霉素,一种新型的螺环缩肽多酮类化合物,来源于 Actinocrispum wychmicini MI503-A4。
J Antibiot (Tokyo). 2022 Oct;75(10):535-541. doi: 10.1038/s41429-022-00560-4. Epub 2022 Sep 7.
2
Macrocyclic polyketides with siderophore mode of action from marine heterotrophic Shewanella algae: Prospective anti-infective leads attenuate drug-resistant pathogens.来自海洋异养藻的具有铁载体作用模式的大环聚酮化合物:有望成为抗感染先导物,可减弱耐药病原体。
J Appl Microbiol. 2021 May;130(5):1552-1570. doi: 10.1111/jam.14875. Epub 2020 Oct 27.
3
Chemical mining of heterotrophic Shewanella algae reveals anti-infective potential of macrocyclic polyketides against multidrug-resistant pathogens.异养希瓦氏菌的化学开采揭示了大环聚酮类化合物对多重耐药病原体的抗感染潜力。
Bioorg Chem. 2021 Mar;108:104533. doi: 10.1016/j.bioorg.2020.104533. Epub 2020 Dec 7.
4
Actinocrispum wychmicini gen. nov., sp. nov., a novel member of the family Pseudonocardiaceae, isolated from soil.放线脆菌属威氏新种,新属,属于假诺卡氏菌科的一个新成员,从土壤中分离得到。
Int J Syst Evol Microbiol. 2016 Nov;66(11):4779-4784. doi: 10.1099/ijsem.0.001429. Epub 2016 Aug 17.
5
Engyodontochones, Antibiotic Polyketides from the Marine Fungus Engyodontium album Strain LF069.来自海洋真菌白齿菌菌株LF069的抗生素聚酮类化合物——恩乔多托酮
Chemistry. 2016 May 23;22(22):7452-62. doi: 10.1002/chem.201600430. Epub 2016 Apr 21.
6
Glenthmycins A-M: Macrocyclic Spirotetronate Polyketide Antibacterials from the Australian Pasture Plant-Derived sp. CMB-PB041.格兰斯他霉素 A-M:源自澳大利亚牧草植物衍生的 sp. CMB-PB041 的大环硫酯多酮类抗生素。
J Nat Prod. 2022 Jun 24;85(6):1641-1657. doi: 10.1021/acs.jnatprod.2c00444. Epub 2022 May 31.
7
Wychimicins E and F from a rare actinomycete of the genus Cryptosporangium.来自稀有放线菌隐孢菌属的威奇霉素 E 和 F。
J Antibiot (Tokyo). 2024 Dec;77(12):847-851. doi: 10.1038/s41429-024-00770-y. Epub 2024 Sep 3.
8
Sydowianumols A, B, and C, Three New Compounds from Discomycete Poculum pseudosydowianum.来自盘菌Poculum pseudosydowianum的三种新化合物——西多威醇A、B和C
Chem Pharm Bull (Tokyo). 2018;66(8):826-829. doi: 10.1248/cpb.c18-00264.
9
Novel Bioactive Polyketides Isolated from Marine Actinomycetes: An Update Review from 2013 to 2019.新型海洋放线菌来源的生物活性聚酮化合物:2013 至 2019 年的研究进展综述
Chem Biodivers. 2020 Dec;17(12):e2000562. doi: 10.1002/cbdv.202000562. Epub 2020 Nov 18.
10
Marine Spirotetronates: Biosynthetic Edifices That Inspire Drug Discovery.海洋螺旋四烯酮:激发药物研发灵感的生物合成建筑。
Mar Drugs. 2019 Apr 19;17(4):232. doi: 10.3390/md17040232.

引用本文的文献

1
Diverse chemotypes of polyketides as promising antimicrobial agents: latest progress.作为有前景的抗菌剂的聚酮化合物的多种化学类型:最新进展
RSC Adv. 2025 Sep 5;15(39):32080-32107. doi: 10.1039/d5ra03414k.
2
Interrogation of an Enzyme Library Reveals the Catalytic Plasticity of Naturally Evolved [4+2] Cyclases.酶文库的研究揭示了天然进化的[4+2]环化酶的催化可塑性。
Chembiochem. 2023 Jul 17;24(14):e202300382. doi: 10.1002/cbic.202300382. Epub 2023 Jun 18.

本文引用的文献

1
Impact of COVID-19 pandemic on hospital onset bloodstream infections (HOBSI) at a large health system.COVID-19 大流行对大型医疗系统院内血流感染(HOBSI)的影响。
Am J Infect Control. 2022 Mar;50(3):245-249. doi: 10.1016/j.ajic.2021.12.018. Epub 2021 Dec 29.
2
Dexamethasone therapy and rates of secondary pulmonary and bloodstream infections in critically ill COVID-19 patients.地塞米松治疗与危重症COVID-19患者继发性肺部和血流感染率
Multidiscip Respir Med. 2021 Oct 28;16(1):793. doi: 10.4081/mrm.2021.793. eCollection 2021 Jan 15.
3
Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave.
危重症 COVID-19 患者在第二波疫情期间发生的细菌性和真菌性呼吸机相关性肺炎。
J Infect Public Health. 2021 Oct;14(10):1375-1380. doi: 10.1016/j.jiph.2021.08.003. Epub 2021 Aug 8.
4
Bloodstream infections in critically ill patients with COVID-19.COVID-19 重症患者血流感染。
Eur J Clin Invest. 2020 Oct;50(10):e13319. doi: 10.1111/eci.13319. Epub 2020 Aug 11.
5
Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections - United States.生命体征:耐甲氧西林和甲氧西林敏感金黄色葡萄球菌血流感染的流行病学和近期趋势 - 美国。
MMWR Morb Mortal Wkly Rep. 2019 Mar 8;68(9):214-219. doi: 10.15585/mmwr.mm6809e1.
6
Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research.耐甲氧西林金黄色葡萄球菌:基础与临床研究概述。
Nat Rev Microbiol. 2019 Apr;17(4):203-218. doi: 10.1038/s41579-018-0147-4.
7
Novel soil bacteria possess diverse genes for secondary metabolite biosynthesis.新型土壤细菌拥有多种多样的次生代谢产物生物合成基因。
Nature. 2018 Jun;558(7710):440-444. doi: 10.1038/s41586-018-0207-y. Epub 2018 Jun 13.
8
Vancomycin-intermediate resistance in Staphylococcus aureus.金黄色葡萄球菌对万古霉素的中介耐药性。
J Glob Antimicrob Resist. 2014 Dec;2(4):213-224. doi: 10.1016/j.jgar.2014.04.006. Epub 2014 Jun 7.
9
Actinocrispum wychmicini gen. nov., sp. nov., a novel member of the family Pseudonocardiaceae, isolated from soil.放线脆菌属威氏新种,新属,属于假诺卡氏菌科的一个新成员,从土壤中分离得到。
Int J Syst Evol Microbiol. 2016 Nov;66(11):4779-4784. doi: 10.1099/ijsem.0.001429. Epub 2016 Aug 17.
10
Natural Products as Sources of New Drugs from 1981 to 2014.1981年至2014年作为新药来源的天然产物
J Nat Prod. 2016 Mar 25;79(3):629-61. doi: 10.1021/acs.jnatprod.5b01055. Epub 2016 Feb 7.